Guanzhong Wu
Nanjing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Molecular mechanisms involved in podocyte EMT and concomitant diabetic kidney diseases: an update.
Journal: Renal failure
Published: April 18, 2017
G004, a synthetic sulfonylurea compound, exerts anti-atherosclerosis effects by targeting SIRT1 in ApoE-/- mice.
Journal: Vascular pharmacology
Published: September 27, 2016
I4, a synthetic anti-diabetes agent, attenuates atherosclerosis through its lipid-lowering, anti-inflammatory and anti-apoptosis properties.
Journal: Molecular and cellular endocrinology
Published: July 15, 2016
Research progress in phytochemistry and biology of Aframomum species.
Journal: Pharmaceutical biology
Published: May 10, 2016
De novo design of caseinolytic protein proteases inhibitors based on pharmacophore and 2D molecular fingerprints.
Journal: Bioorganic & medicinal chemistry letters
Published: December 24, 2014
Reno-protection of G004, a novel anti-diabetic sulfonylurea in db/db mice.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: October 02, 2014
Oroxylin A reverses P-glycoprotein-mediated multidrug resistance of MCF7/ADR cells by G2/M arrest.
Journal: Toxicology letters
Published: December 03, 2012
Genistein: a promising therapeutic agent for obesity and diabetes treatment.
Journal: European journal of pharmacology
Published: June 05, 2012
Interference by metabolites and the corresponding troubleshooting during the LC-MS/MS bioanalysis of G004, a bromine-containing hypoglycemic agent.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
Published: January 20, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026